The School of Life Sciences in Dundee is the top-ranked university institution for biological sciences research in the U.K. (The Research Excellence Framework 2014), and is proud of its reputation as one of the most dynamic international centres for molecular cell biology, with outstanding facilities for research. In 2015, Sir Paul Nurse opened a new wing of the building, called the Discovery Centre, with the aim of promoting the links between fundamental research and more translational and interdisciplinary studies.
The MRC Protein Phosphorylation and Ubiquitylation Unit focuses on the understanding of the biological roles of ubiquitylation and phosphorylation, and their links to human disease. Funding from the Medical Research Council supports cutting edge facilities, and the unit provides an exciting and collaborative research environment. One key feature of the unit is its long-standing collaboration with a number of the world’s leading pharmaceutical companies, to form the ‘Division of Signal Transduction Therapy’. This allows the scientists studying phosphorylation and ubiquitylation to interact with major pharmaceutical companies on a regular basis, to help accelerate the early stages of drug discovery.